BetterDoc bringt Sie zum richtigen Arzt.
Auf Basis objektiver Qualitätskriterien. Und bewiesenem Behandlungserfolg.

Prof. Dr. med. Claus Ulrich Niederau

Prof. Dr. med.
Claus Ulrich Niederau

Facharzt für Innere Medizin

Diabetologie, Gastroenterologie

  • Chefarzt Klinik für Innere Medizin

St. Josef-Hospital

Mülheimer Str. 83
46045 Oberhausen

Behandlungsrelevante Informationen

Ärztliche Ausbildung

  • Facharzt-Ausbildung im Bereich Innere Medizin
  • Schwerpunkte: Gastroenterologie
  • Zusatzqualifikationen: Diabetologie

Sprachkenntnisse

Englisch

Wissenschaftliche Informationen

Forschungsschwerpunkte

  • Virushepatitis, Hämochromatose, M. Wilson, M. Gaucher, Pankreaserkarnkungen, Crohn, Colitis, GI-Hormone

Mitglied in folgenden Fachgesellschaften

  • Deutsche Diabetes Gesellschaft (DDG)
  • American Gastroenterological Association (AGA)
  • Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)

Wissenschaftliche Preise

  • Klinische Gastroenterologie (DGVS), AGA Forschungspreis

Promotion

  • 1979: Titel „Peptid-PABA Test bei exokriner Pankreasinsuffizienz“

Habilitation

  • 1988: Untersuchungen zu Pathophysiologie, Diagnostik und Therapie der akuten Pankreatitis

Ausgewählte Publikationen

  • Heintges T, Niederau C, Goertz G, Strohmeyer G - Interferon treatment causes deterioration of lichen ruber planus but not of acute intermittent porphyria. Journal of Hepatology 11/1994 1151-1153
  • Niederau C, Sonnenberg A, Müller J, Erckenbrecht J, Scholten T, Fritsch WP: - Sonographic measurements of normal liver, spleen, pancreas, and portal vein. . Radiology 06/1983 537-540
  • Niederau C, Sonnenberg A, Müller J: - Liver size evaluated by ultrasound: ROC curves for hepatitis and alcoholism. Gastroenterology 06/1984 503-505
  • Niederau C, Ferrell LD, Grendell JH - Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin. Gastroenterology 01/1985 1192-1204
  • Niederau C, Grendell JH - Intracellular vacuoles in experimental acute pancreatitis are an acidified compartment. Journal of Clinical investigation 01/1988
  • Niederau C, Crass RA, Silver J, Ferrell LD, Grendell JH - Effects of hydration, oxygenation, peritoneal lavage, and a new protease inhibitor on experimental acute pancreatitis. Gastroenterology 10/1988 1648-1657
  • Niederau C, Heintges T, Rovati L, Strohmeyer G - Effects of loxiglumide on gallbladder emptying after a meal or after intravenous infusion of caerulein in healthy human volunteers. Gastroenterology 08/1989 1331-1337
  • Niederau C, Lüthen R, Niederau M, Strohmeyer G, Ferrell LD, Grendell JH - Pancreatic exocrine secretion in acute experimental pancreatitis. Gastroenterology 02/1990 1120-1127
  • Niederau C, Grendell JH - Diagnosis of chronic pancreatitis. Gastroenterology 03/1985 1973-1995
  • Niederau C, Grendell JH - Diagnosis of pancreatic carcinoma. Pancreas 04/1991 282-290
  • Niederau C, Karaus M - Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome. Gastroenterology 06/1992 1889-1998
  • Niederau C - The effects of CCK on pancreatic function and morphology. Annals of the New York Academy of Sciences 10/1994 180-196
  • Niederau C, Littauer A, Strohmeyer G - Glucocerebrosidase for treatment of Gaucher's disease. Journal of Hepatology 02/1994 610-617
  • Niederau C, Pohlmann U, Lübke H, Thomas L - Prophylactic antibiotic treatment in herapeutic or complicated diagnostic ERCP: results of a randomized controlled clinical study. Gastrointestinal Endoscopy 03/1994 533-537
  • Niederau C, Fischer R, Pürschel A, Stremmel W, Häussinger D, Strohmeyer G - Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 05/1996 1007-1019
  • Niederau C, Heintges T, Lange S. Goldmann G, Niederau C, Mohr L, Häussinger D - Long-term survival in patients with hereditary hemochromatosis. . New England Journal of Medicine 04/1996 1422-1427
  • Niederau C - Iron overload and atherosclerosis. Hepatology 05/2000 569-574
  • Niederau C, Hippenstiel C - Conservative management of acute pancreatitis: complications and outcome in a community-based hospital. Pancreas 01/2006 67-79
  • Niederau C, Lange S, Frühauf M, Thiel A - Cutaneous signs of liver disease: value for prognosis of severe fibrosis and cirrhosis. Liver International 04/2008 659-666
  • Niederau C, Hüppe D, Zehnter E, Möller B, Heyne R, Christensen S, Pfaff R, Theilmeier A, Alshuth U, Mauss S - Chronic hepatitis C: treat of wait? Medical decision making in clinical practice. World Journal of gastroenterology 03/2012 55-65
  • Niederau C, Mauss S, Böker K, Lutz T, Heyne R, Moog G, John C, Witthöft T, Alshuth U, Hüppe D. - Non-compliance with guidelines for treatment of hepatitis C is frequent in daily practice. European Journal of Gastroenterology and Hepatology 01/2014 65-73
  • Sonnenberg A, Erckenbrecht J, Peter P, Niederau C - Detection of Crohn's disease by ultrasound. Gastroenterology 03/1982 430-434
  • Thienhaus R, Niederau C, Tennie U - Exocrine pancreatic insufficiency. Chymotrypsin determination and peptide PABA test. Deutsche Medizinische Wochenschrift 02/1978 1358-1360
  • Kley HK, Stremmel W, Niederau C, Hehrmann R, Shams O, Strohmeyer G, Krüskemper HL - Androgen and estrogen response to adrenal and gonadal stimulation in idiopa¬thic hemochromatosis: evidence for decreased estrogen formation. Hepatology 07/1985 251-256
  • Stremmel W, Meyerrose KW, Niederau C, Strohmeyer G - Diagnosis, treatment, and prognosis of Wilson's disease: Evaluation of 52 patients. Annals of Internal Medicine 05/1991 720-726
  • Niederau C, Van Dyke RW, Scharschmidt BF, Grendell JH - Rat pancreatic zymogen granules: an actively acidified compartment.. Gastroenterology 07/1986 1433-1442
  • Niederau C, Liddle RA, Williams JA, Grendell JH - Pancreatic growth: interaction of exogenous chole-cystokinin, a protease inhibitor, and a cholecystokinin re¬ceptor antagonist in mice. Gut 04/1997
  • Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hurter D, Nawrocki M, Kruska L, Hensel F, Petry W, Haussinger D - Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 07/1998 1687-1695
  • Niederau C, Niederau CM, Lange S, Littauer A, Abdel-Jalil N, Maurer M, Haussinger D, Strohmeyer G - Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Annals of Internal Medicine 03/1998 337-345
  • Lüthen R, Ferrell LD, Grendell JH, Niederau C - Subcellular distribution of pancreatic digestive and lysosomal enzymes in experimental acute pancreatitis. Gastroenterology 12/1995 573-581
  • von Herbay A, Stahl W, Niederau C, von Laar J, Strohmeyer G, Sies H - Diminished plasma levels of vitamin E in patients with severe viral hepatitis. Free Radical Research 05/1996 461-466
  • Klonowski-Stumpe H, Schreiber R, Grolik M, Schulz HU, Haussinger D, Niederau C - Effect of oxidative stress on cellular functions and cytosolic free calcium of rat pancreatic acinar cells. American Journal of Physiology 09/1997
  • Han B, Klonowski-Stumpe H, Sata N, Lüthen R, Schliess F, Häussinger D, Niederau C - Cell volume changes modulate cholecystokinin and carbachol stimulated amylase release in isolated rat pancreatic acini. Gastroenterology 05/1997 1756-1766
  • von Herbay A, Stahl W, Niederau C, Sies H - Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study. Free Radic Res 10/1997 599-605
  • von Herbay A, Frieling T, Niederau C, Haussinger D - Solitary hepatic lesions with a hypoechoic rim: value of color Doppler sonography. American Journal of Roentgenology 04/1998
  • Mohr L, Heintges T, Hensel F, Niederau C, Haussinger D - Treatment of autoimmune cholangitis. Digestive Diseases and Sciences 08/1998 2160-2163
  • vom Dahl S, Harzer K, Rolfs A, Albrecht B, Niederau C, Vogt C, van Weely S, Aerts J, Muller G, Häussinger D - Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase -1 exon 8 splice junction mutation. Journal of Hepatology 04/1999 741-746
  • Erhardt A, Reineke U, Blondin D, Gerlich WH, Adams O, Heintges T, Niederau C, Häussinger D - Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B. . Hepatology 11/2000 716-725
  • Poll LW, Koch JA, vom Dahl S, Loxtermann E, Sarbia M, Niederau C, Häussinger D, Mödder U - Extraosseous manifestation of Gaucher's disease type I: MR and histological appearance. European Journal of Radiology 02/2000 861-869
  • Heintges T, Petry W, Kaldewey M, Erhardt A, Wend UC, Gerlich WH, Niederau C, Häussinger D. - Combination therapy of active HBsAg vaccination and interferon-alpha in interferon-alpha nonresponders with chronic hepatitis B. Digestive Diseases and Sciences 05/2001 901-906
  • Erhardt A, Maschner-Olberg A, Mellenthin C, Kappert G, Adams O, Donner A, Willers R, Niederau C, Häussinger D - HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis. Journal of Hepatology 03/2003 335-343
  • Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G: - Survival and causes of death in primary hemochromatosis. . New England Journal of Medicine 03/1996 281-291
  • Witthöft T, Möller B, Wiedmann KH, Mauss S, Link R, Lohmeyer J, Lafrenz M, Gelbmann CM, Hüppe D, Niederau C, Alshuth U. - Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice. Journal of Viral Hepatitis 11/2007 788-796
  • Phatak P, Brissot P, Wurster M, Adams PC, Bonkovsky HL, Gross J, Malfertheiner P, McLaren - A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron . Hepatology 11/2011 1671-1679
  • Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht J. - Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group. Lancet 09/1998 1426-1432
  • Lüthen R, Ferrell LD, Grendell JH, Niederau C - Intrapancreatic activation of digestive zymogens during caerulein pancreatitis in rats. A possible role for changes in ATP and glutathione levels. American Journal of Physiology 09/1995
  • Biegstraaten M, Mengel E, Maródi L, Petakov M, Niederau C, Giraldo P, Hughes D, Mrsic M, Mehta A, Hollak CE, van Schaik IN - Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study. Brain 03/2010 2909-2919
  • Bruix J, Poynard T, Colombo M, Schiff E, Burak K, Heathcote EJ, Berg T, Poo JL, Mello CB, - A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron . Hepatology 05/2011 1990-1991
  • Biegstraaten M, Wesnes KA, Luzy C, Petakov M, Mrsic M, Niederau C, Giraldo P, Hughes D, Mehta - The cognitive profile of type 1 Gaucher disease . J Inherit Metab Di 10/2012 1093-1099
  • Buster EHCJ, Hansen BE, Buti M, Delwaide J, Niederau C, et al. - PEGInterferon alpha-2b is safe and effective in HBeAg positive chronic hepatitis B patients with adva. Hepatology 04/2007
  • Niederau C, Grendell JH, Rothman SS. - Effects of proglumide on ductal and basolateral secretion of pancreatic digestive enzymes.. American Journal of Physiology 07/1985
  • Niederau C, Liddle RA, Ferrell LD, Grendell JH. - Beneficial effects of CCK-receptor blockade and inhi-bition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice: evidence for cholecy¬stokinin as a major factor in the development of acute pancreatitis. Journal of Clinicical Investigation 05/1996 1056-1063
  • Niederau C, Grendell JH, Rothman SS. - Digestive end products release pancreatic enzymes from particulate cellular pools, particularly zymogen granules. Biochim Biophysica Acta 02/1997 281-291
  • Heintges T, Mohr L, Hensel F, Petry W, Borchard F, Häussinger D, Niederau C - Value of liver biopsy prior to interferon therapy for chronic viral hepatitis. Digestive Diseases and Sciences 02/1998 1562-1565
  • Flamm SL, Lawitz E, Jacobson I, Bourlière M, Hezode C, Vierling JM, Bacon BR, Niederau C, - Boceprevir With Peginterferon Alfa-2a-Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection. Clinical Gastroenterology and Hepatology 02/2013 81-87
  • Yildiz Y, Hoffmann P, vom Dahl S, Breiden B, Sandhoff R, Niederau C, Horwitz M, Karlsson S, - Functional and genetic characterization of the non-lysosomal . Orphanet Journal of Rare Diseases 07/2013 151-160
  • Arama V, Hakan Leblebicioglu H, Krzysztof Simon K, Jean Pierre Zarski JP, Niederau C - Chronic hepatitis B monitoring and treatment patterns in five European countries with . Antiviral Therapy 02/2014
  • Niederau C, Strohmeyer G: - Hemochromatosis. Conn's current therapy, 39th Edition. Saunders Company, Philadelphia 1987 07/1986 117-148
  • Niederau C, Müller J, Sonnenberg A, Scholten T, Erckenbrecht J, Fritsch WP, Brüster T, Strohmeyer G - Extrahepatic bile ducts in healthy subjects, in patients with cholelithiasis and in postcholecystectomy patients. Journal of Clinical Ultrasound 02/1983 23-27
  • Niederau C - Morbus Gaucher diagnostizieren und behandeln. Thieme Refresher Innere Medizin 02/2013 1-16